in Patients With SCAD Undergoing Complex PCI, the RESPONSE Study"

NCT04251039 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2022-07-28

No results posted yet for this study

Summary

Evaluation of Efficacy/Safety in Cangrelor use in patients with SCAD undergoing complex PCI.

Prospective, observational, multicenter registry.

Conditions

  • Coronary Disease

Sponsors & Collaborators

  • Fondazione GISE Onlus

    lead OTHER

Principal Investigators

  • Alfredo Marchese, MD, PhD · Ospedale Santa Maria (BA)

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-31
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04251039 on ClinicalTrials.gov